Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline in mild to moderate Alzheimer's disease
NCT00744978Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in Alzheimer's disease (AD), sponsored by Pfizer. Started Jul 2009; status: completed.
02
Drugs
varenicline
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00744978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744978.